Pareen Vora

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Cardiovascular Risk Factors

Top Venues

International journal of clinical practice

Science progress

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Sascha van Boemmel-Wegmann, Kenneth W Altman, Ron Herrera, Philippe Vieira Pires, Priscilla F A Pichardo, Pareen Vora
Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: A descriptive study. Science progress 107 (1) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Sascha van Boemmel-Wegmann, Kenneth W Altman, Ron Herrera, Philippe Vieira Pires, Priscilla F A Pichardo, Pareen Vora
Characteristics of adults with potential refractory chronic cough identified using an algorithm designed for administrative claims databases: A descriptive study. Science progress 107 (1) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Paul M Overton, Mark Toshner, Claire Mulligan, Pareen Vora, Sylvia M Nikkho, Jan de Backer, Ben R Lavon, Frederikus A Klok, null null
Pulmonary thromboembolic events in COVID-19-A systematic literature review. Pulmonary circulation 12 (3) (2022)
Pareen Vora, Montse Soriano Gabarró, Beth Russell, Henry Morgan Stewart
Long-Term Adherence and Persistence to Low-Dose Aspirin for the Prevention of Cardiovascular Disease: A Population-Based Cohort Study. International journal of clinical practice 2022 (2022)
Pareen Vora, Henry Morgan Stewart, Beth Russell, Alex Asiimwe, Gunnar Brobert
Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States. International journal of clinical practice 2022 (2022)
Pareen Vora, Montse Soriano Gabarró, Beth Russell, Henry Morgan Stewart
Long-Term Adherence and Persistence to Low-Dose Aspirin for the Prevention of Cardiovascular Disease: A Population-Based Cohort Study. International journal of clinical practice 2022 (2022)
Luis Alberto García-Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Pareen Vora, Lucía Cea Soriano
Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study. Journal of clinical medicine 9 (4) (2020)
Ana Ruigómez, Gunnar Brobert, Pareen Vora, Luis Alberto García-Rodríguez
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network. Pharmacoepidemiology and drug safety 30 (2) (2020)
Luis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, Ana Ruigómez, Cristina Rebordosa, Irene D Bezemer, Ron M C Herings, Saad Shakir, Alison Evans, Miranda Davies, Kiliana Suzart-Woischnik, Pareen Vora, Yanina Balabanova, Montse Soriano Gabarró, Gunnar Brobert
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert opinion on drug safety 19 (11) (2020)
Venkatesh Kumar Gurusamy, Gunnar Brobert, Pareen Vora, Leif Friberg
Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registers. BMC cardiovascular disorders 19 (1) (2019)
Pareen Vora, Esther Artime, Montse Soriano-Gabarró, Nawab Qizilbash, Vineet Singh, Alex Asiimwe
A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post-Authorization Studies. Pharmacoepidemiology and drug safety 27 (7) (2018)